Ling Peng is a leading expert in developing functional dendrimer nanosystems for drug delivery in biomedical applications. She has successfully established bio-inspired structurally flexible and self-assembling dendrimer nanosystems for drug and nucleic acid delivery. She is currently a research director at the French National Scientific Research Center (CNRS), and a principle investigator at the Centre Interdisciplinaire de Nanoscience de Marseille (CINaM).
Abstract
Nanotechnology is widely expected to bring breakthroughs in specific delivery of the right therapeutic agent to the right patient at the right disease. Dendrimers are ideal nanocarriers for drug delivery by virtue of their uniquely well-defined structures and multivalent cooperativity confined within a nanosized volume. We have established bioinspired structurally flexible and self- assembling supramolecular dendrimers for drug delivery. These dendrimers are excellent nanocarriers for personalized medicine. They are able to form modular, responsive and adaptive nanosystems, and effectively deliver various chemo- and bio-therapeutics as well as imaging agents for precise diagnosis and personalized treatment in various disease’s models. These studies have offered new perspectives in dendrimer nanotechnology based biomedical applications.
Pharmaceutics
Drug Delivery Techniques
Drug Designing Methodologies
Drug Discovery and Development
Pharmaceutical, Medicinal and Organic Chemistry
Green Chemistry in Pharma Industry
Heterocyclic Chemistry
Nano-medicine and Nano Technology
Novel Drug Delivery System (NDDS) and Techniques in Pharmaceutics